BIOAMA pharmaceutical logistics container at Hong Kong port
Hong Kong · Shanghai · Germany · Italy

Your trusted bridge between China, Asia, and the world’s pharmaceutical markets.

Connecting certified Asian manufacturers with global healthcare partners through trusted sourcing, regulatory expertise, and long-term collaboration.

2018
Founded in Hong Kong
30+
Years of pharma experience
50+
Advanced generic drug projects
40+
Chemical product projects
01 — Product lines

Four core product lines

Sourcing, supplier qualification and compliance across the pharmaceutical and chemical value chain.

Laboratory vials and raw pharmaceutical ingredients under quality control.

APIs & Intermediates

Active pharmaceutical ingredients and intermediates from qualified manufacturers in China and India, backed by CoAs and audits.

Packaged pharmaceutical tablets and capsules ready for regulated distribution.

Innovative & Generic Drugs

Finished dosage forms and licensing-in and licensing-out projects for advanced generic and innovative products.

Chemical and cosmetic raw material samples in glass jars on a laboratory bench.

Chemicals & Cosmetic Raw Materials

Fine chemicals and cosmetic raw materials supplied with full specification and traceability documentation.

Assorted dietary supplement capsules and nutritional health products.

Dietary Supplements

Nutraceuticals and functional ingredients formulated for EU, Asian and international retail channels.

02 — Why BIOAMA

Why BIOAMA

A regulated industry demands accountable partners. We combine 10+ years on the ground in China with pharma-specific expertise.

Faster, informed decisions

Market and feasibility assessments that let you decide on evidence, not assumptions.

Reduced regulatory risk

Supplier pre-qualification, audit support and quality checks before commitments are made.

Clear China communication

A reliable interface with Chinese partners, bridging two business cultures and languages.

Long-term partnerships

Structured, long-term cooperation with producers in China and India — and with our clients.

Discuss your sourcing or licensing project with our team.

Response within one business day.

INQUIRE